480
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Commentary on “Moniz and Beigi's maternal immunization clinical experiences, challenges, and opportunities in vaccine acceptance”

Pages 2571-2573 | Received 03 Aug 2014, Accepted 16 Aug 2014, Published online: 13 Nov 2014

Abstract

Maternal immunization faces an array of structural, sociocultural, and individual challenges that must be effectively addressed to realize widespread improvements in vaccination uptake. As Moniz and Beigi correctly detail in their review, immunization during this period offers unique opportunity to make substantial improvements in maternal and neonatal health. Moving beyond the existing Health Belief Model, we learn that immunization uptake can be significantly improved by shaping messages, addressing logistical challenges such as out-of-pocket (i.e., “copay”) barriers, and delivering provider education on maternal immunization to encourage future provider recommendations and facilitate the patient convenience of in-office vaccine administration. The resulting approach of “Educate, Recommend, Normalize, Maximize Convenience” is consistent with the evidence on maternal immunization. In its systematic application, such a model may usher in unprecedented opportunity to improve immunization uptake in decades ahead.

The sweeping analyses given to the subject of maternal immunization by Moniz and Beigi provide insight on the unique challenges associated with improving vaccine uptake during pregnancy. As the authors correctly describe, immunization during this period offers unique opportunity to make substantial improvements in maternal and neonatal health. Despite recommendations from a number of entities including The Advisory Committee on Immunization Practices (ACIP) and The American College of Obstetricians and Gynecologists (ACOG), the authors highlight key coverage concerns in this field.Citation1-5 Notably, immunization uptake among pregnant women lacking contraindication remains suboptimal (at rates estimated to be ≤50%) for inactivated seasonal influenza, and tetanus and diphtheria toxoid and acellular pertussis (Tdap) vaccination.Citation6-8 As the influenza vaccination rate has stabilized over the past four years following the introduction of the H1N1 vaccine (over the previous 15% influenza vaccine coverage rate), they call attention to the fact that it is unlikely that the Healthy People 2020 goal of 80% coverage among this population will be attained.Citation9 The situation is even more concerning for Tdap with an estimated baseline uptake in 2011 of 3% among pregnant women and a broader need to promote Tdap “cocooning” immunization strategies among close contacts of infants.Citation10,11 Moreover, there is a possibility that candidate vaccines in the development pipeline (e.g., group B streptococcus and respiratory syncytial virus) will yield even more use recommendations for pregnant women thus intensifying pressure to find effective immunization promotion approaches.Citation12,13

Improving maternal immunization begins with understanding why people do or do not choose to immunize.Citation14 Moniz and Beigi provide an excellent overview of the results from maternal immunization studies of which they detail an array of socioecological influences ranging from ability to pay (i.e., a healthcare “structural” determinant) to social norms and personal perceived illness vulnerability (i.e.,”individual” factors). They situate several of these factors within the Health Belief Model (HBM), a conceptual framework that has been used for understanding immunization compliance.Citation15

Moniz and Beigi offer advancement over the existing HBM model that is limited in its guidance on directionality or effect magnitude of its component influences.Citation16 In their adapted maternal immunization version, Moniz and Beigi incorporate the HBM components of perceived disease vulnerability (susceptibility and severity), perceived immunization benefits and costs, cues to action and self-efficacy yet they provide more explanatory power of the model. In this current version, the authors conceptualize maternal immunization pathway influences by placing message framing effects and social norm influences (“cues to action”) and perceived regret associated with immunization decision-making (“to vaccinate or not”) as mediating factors on pregnant women's vaccination acceptance. Thus, provides visual insight on how to trigger a positive “chain reaction” associated with favorable immunization decision-making. The related narrative on this figure describes the manner in which immunization uptake can be significantly improved by shaping messages, addressing logistical challenges such as out-of-pocket (i.e., “copay”) barriers, and delivering provider education on maternal immunization to encourage future provider recommendations and facilitate the patient convenience of in-office vaccine administration.

Figure 1. Modified health belief model as a theoretical framework for maternal acceptance of vaccination.32

Figure 1. Modified health belief model as a theoretical framework for maternal acceptance of vaccination.32

The resulting approach of “Educate, Recommend, Normalize, Maximize Convenience” proposed by the authors is consistent with the evidence on maternal immunization. In its systematic application, the authors correctly assert that it brings forth unprecedented opportunity to improve immunization uptake in decades ahead. It is important to recognize that education is viewed as a two-pronged endeavor. In this model, education starts with the provider who is a key influencer and facilitator of vaccine outcomes. The authors envision the provider as benefitting from education on vaccine messaging, counseling, and mediation. Inasmuch, the provider is much better equipped to manage multiple and often conflicting personal viewpoints women present, but also those of spouses, partners, family members, and larger social influences including those presented by media when women come into their offices.

Provider-delivered recommendations and office-based immunization administration are also key factors highlighted in the strategy to improve maternal immunization acceptance. The authors found overwhelming evidence on the need for provider recommendation to facilitate pregnant women's immunization decision-making.Citation14,Citation17-20 Yet, provider recommendation results from effective continuing medical education provided by ACOG and others on the need for immunization during pregnancy. This model suggests a need for more evidence-based information about vaccine safety and immunogenicity profiles as well as neonatal protection directed to providers who, in turn, will be able to recommend immunization to women for whom contraindication does not exist.

By adding immunization reminders to electronic medical records and offering the “in-house” convenience of vaccine administration in the course of a clinical encounter, the authors also bring forth the important issue of convenience that leads to immunization normalization in health care delivery. For many pregnant women who may hear what their provider says, but lack the ability (or “self-efficacy”) to act on the immunization recommendation due to cost constraints or lack of transportation to get the vaccine, the convenience of getting immunized in the doctor's office offers enormous advantage to achieve greater population uptake. This model offers compelling reasons to therefore introduce immunization into standard obstetrical care delivery.

Moniz and Beigi offer provocative findings on the relationship of several structurally- and socially-driven clinical and health delivery realities. By combining the results from several studies, they have introduced an excellent opportunity to implement a new evidence-based, integrative model that combines education, provider persuasion, shifts in social norms, and convenience to patients in order to facilitate greater maternal immunization well into the future.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

References

  • Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months — Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011; 60:1424-6; PMID:22012116
  • Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women–Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013; 62:131-5; PMID:23425962
  • Arya SC, Agarwal N, Agarawal S. Apropos “Incorporating immunizations into routine obstetric care to facilitate health care practitioners in implementing maternal immunization recommendations”. Hum Vaccin Immunother 2014; 10; In press; PMID:24637391; http://dx.doi.org/10.4161/hv.28496
  • Webb H, Street J, Marshall H. Incorporating immunizations into routine obstetric care to facilitate Health Care Practitioners in implementing maternal immunization recommendations. Hum Vaccin Immunother 2014; 10; In press; PMID:24509790
  • American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 468: Influenza vaccination during pregnancy. Obstet Gynecol 2010; 116:1006; PMID:20859176; http://dx.doi.org/10.1097/AOG.0b013e3181fae845
  • Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, et al.; Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59(RR-8):1-62; PMID:20689501
  • Lu P, Bridges CB, Euler GL, Singleton JA. Influenza vaccination of recommended adult populations, U.S., 1989-2005. Vaccine 2008; 26:1786-93; PMID:18336965; http://dx.doi.org/10.1016/j.vaccine.2008.01.040
  • Centers for Disease Control and Prevention (CDC). Influenza vaccination coverage among pregnant women–United States, 2012-13 influenza season. [eng.]. MMWR Morb Mortal Wkly Rep 2013; 62:787-92; PMID:24067583
  • Healthy People 2020 Topics and Objectives: Immunizations and Infectious Diseases, IID-12.10. Available at http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=23. Accessed March 2, 2014.
  • Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, Rebmann CA, Gabel J, Schauer SL, Lett SM. Infant pertussis: who was the source? Pediatr Infect Dis J 2004; 23:985-9; PMID:15545851; http://dx.doi.org/10.1097/01.inf.0000145263.37198.2b
  • Murphy TV, Slade BA, Broder KR, Kretsinger K, Tiwari T, Joyce PM, Iskander JK, Brown K, Moran JS; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57(RR-4):1-51; PMID:18509304
  • Novartis Vaccines. Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women. ClinicalTrials.gov Identifier NCT02046148. Available at: https://clinicaltrials.gov/ct2/show/NCT02046148?term=gbs&rank=8. Accessed June 4, 2014.
  • ClinicalTrials.gov. Ongoing clinical trials related to maternal immunization. Available at: https://clinicaltrials.gov/ct2/results?term=maternal+immunization. Accessed June 4, 2014.
  • Frew PM, Saint-Victor DS, Owens LE, Omer SB. Socioecological and message framing factors influencing maternal influenza immunization among minority women. Vaccine 2014; 32:1736-44; PMID:24486366; http://dx.doi.org/10.1016/j.vaccine.2014.01.030
  • Pacis CR. The relationship of the health belief model and health locus of control concepts to immunization compliance. ANPHI Pap 1990; 25:2-12; PMID:2104030
  • Davidhizar R. Critique of the health-belief model. J Adv Nurs 1983; 8:467-72; PMID:6558081; http://dx.doi.org/10.1111/j.1365-2648.1983.tb00473.x
  • Frew PM, Saint-Victor DS, Owens LE, Omer SB. Socioecological and message framing factors influencing maternal influenza immunization among minority women. Vaccine 2014; 32:1736-44; PMID:24486366; http://dx.doi.org/10.1016/j.vaccine.2014.01.030
  • Marsh HA, Malik F, Shapiro E, Omer SB, Frew PM. Message Framing Strategies to Increase Influenza Immunization Uptake Among Pregnant African American Women. Matern Child Health J 2013; In press; PMID:24337776
  • Blanchard-Rohner G, Meier S, Ryser J, Schaller D, Combescure C, Yudin MH, Burton-Jeangros C, de Tejada BM, Siegrist CA. Acceptability of maternal immunization against influenza: the critical role of obstetricians. J Matern Fetal Neonatal Med 2012; 25:1800-9; PMID:22339083; http://dx.doi.org/10.3109/14767058.2012.663835
  • Maher L, Hope K, Torvaldsen S, Lawrence G, Dawson A, Wiley K, Thomson D, Hayen A, Conaty S. Influenza vaccination during pregnancy: coverage rates and influencing factors in two urban districts in Sydney. Vaccine 2013; 31:5557-64; PMID:24076176; http://dx.doi.org/10.1016/j.vaccine.2013.08.081
  • Moniz MH, Beigi RH. Maternal immunization: Clinical experiences, challenges, and opportunities in vaccine acceptance. [Epub ahead of print]. Hum Vaccin Immunother 2014; 10; PMID:24964048; http://dx.doi.org/10.4161/hv.29588

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.